GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adagio Medical Holdings Inc (NAS:ADGM) » Definitions » EV-to-FCF

ADGM (Adagio Medical Holdings) EV-to-FCF : 0.18 (As of Jan. 19, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Adagio Medical Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Adagio Medical Holdings's Enterprise Value is $-2.51 Mil. Adagio Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-14.01 Mil. Therefore, Adagio Medical Holdings's EV-to-FCF for today is 0.18.

The historical rank and industry rank for Adagio Medical Holdings's EV-to-FCF or its related term are showing as below:

ADGM' s EV-to-FCF Range Over the Past 10 Years
Min: -4.97   Med: -1.85   Max: 0.22
Current: 0.18

During the past 3 years, the highest EV-to-FCF of Adagio Medical Holdings was 0.22. The lowest was -4.97. And the median was -1.85.

ADGM's EV-to-FCF is ranked better than
97.57% of 370 companies
in the Medical Devices & Instruments industry
Industry Median: 27.565 vs ADGM: 0.18

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-01-19), Adagio Medical Holdings's stock price is $0.7745. Adagio Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-2.216. Therefore, Adagio Medical Holdings's PE Ratio (TTM) for today is At Loss.


Adagio Medical Holdings EV-to-FCF Historical Data

The historical data trend for Adagio Medical Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagio Medical Holdings EV-to-FCF Chart

Adagio Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
EV-to-FCF
- - -

Adagio Medical Holdings Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only - - - - -1.66

Competitive Comparison of Adagio Medical Holdings's EV-to-FCF

For the Medical Devices subindustry, Adagio Medical Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adagio Medical Holdings's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Adagio Medical Holdings's EV-to-FCF falls into.



Adagio Medical Holdings EV-to-FCF Calculation

Adagio Medical Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-2.512/-14.012
=0.18

Adagio Medical Holdings's current Enterprise Value is $-2.51 Mil.
Adagio Medical Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adagio Medical Holdings  (NAS:ADGM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Adagio Medical Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.7745/-2.216
=At Loss

Adagio Medical Holdings's share price for today is $0.7745.
Adagio Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.216.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Adagio Medical Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Adagio Medical Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Adagio Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
26051 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.